Articles - 4erz mentioned but not cited (3)
- Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases. Dharmarajan V, Lee JH, Patel A, Skalnik DG, Cosgrove MS. J Biol Chem 287 27275-27289 (2012)
- Disentangling the recognition complexity of a protein hub using a nanopore. Mayse LA, Imran A, Larimi MG, Cosgrove MS, Wolfe AJ, Movileanu L. Nat Commun 13 978 (2022)
- Evaluation of Nanopore Sensor Design Using Electrical and Optical Analyses. Mayse LA, Imran A, Wang Y, Ahmad M, Oot RA, Wilkens S, Movileanu L. ACS Nano 17 10857-10871 (2023)
Reviews citing this publication (20)
- Hijacked in cancer: the KMT2 (MLL) family of methyltransferases. Rao RC, Dou Y. Nat Rev Cancer 15 334-346 (2015)
- Inhibitors of Protein Methyltransferases and Demethylases. Kaniskan HÜ, Martini ML, Jin J. Chem Rev 118 989-1068 (2018)
- Moonlighting with WDR5: A Cellular Multitasker. Guarnaccia AD, Tansey WP. J Clin Med 7 E21 (2018)
- On WD40 proteins: propelling our knowledge of transcriptional control? Migliori V, Mapelli M, Guccione E. Epigenetics 7 815-822 (2012)
- Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin. Bochyńska A, Lüscher-Firzlaff J, Lüscher B. Cells 7 E17 (2018)
- The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer. Lu K, Tao H, Si X, Chen Q. Front Oncol 8 502 (2018)
- Targeting human SET1/MLL family of proteins. Vedadi M, Blazer L, Eram MS, Barsyte-Lovejoy D, Arrowsmith CH, Hajian T. Protein Sci 26 662-676 (2017)
- KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies. Lavery WJ, Barski A, Wiley S, Schorry EK, Lindsley AW. Clin Epigenetics 12 10 (2020)
- Activation and regulation of H2B-Ubiquitin-dependent histone methyltransferases. Worden EJ, Wolberger C. Curr Opin Struct Biol 59 98-106 (2019)
- Epigenetic targets and drug discovery: part 1: histone methylation. Liu Y, Liu K, Qin S, Xu C, Min J. Pharmacol Ther 143 275-294 (2014)
- Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins. Li X, Song Y. J Hematol Oncol 14 56 (2021)
- Diverse roles of WDR5-RbBP5-ASH2L-DPY30 (WRAD) complex in the functions of the SET1 histone methyltransferase family. Ali A, Tyagi S. J Biosci 42 155-159 (2017)
- SET1/MLL family of proteins: functions beyond histone methylation. Sugeedha J, Gautam J, Tyagi S. Epigenetics 16 469-487 (2021)
- Aberrant Activity of Histone-Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis. Poreba E, Lesniewicz K, Durzynska J. Int J Mol Sci 21 E9340 (2020)
- Structural Paradigms in the Recognition of the Nucleosome Core Particle by Histone Lysine Methyltransferases. Janna A, Davarinejad H, Joshi M, Couture JF. Front Cell Dev Biol 8 600 (2020)
- Keeping them all together: β-propeller domains in histone methyltransferase complexes. Bergamin E, Blais A, Couture JF. J Mol Biol 426 3363-3375 (2014)
- Recent Progress in Modulation of WD40-Repeat Domain 5 Protein (WDR5): Inhibitors and Degraders. Gurung R, Om D, Pun R, Hyun S, Shin D. Cancers (Basel) 15 3910 (2023)
- Catching Nucleosome by Its Decorated Tails Determines Its Functional States. Sehrawat P, Shobhawat R, Kumar A. Front Genet 13 903923 (2022)
- Chemically induced degradation of epigenetic targets. Kabir M, Yu X, Kaniskan HÜ, Jin J. Chem Soc Rev 52 4313-4342 (2023)
- Histone lysine methyltransferase-related neurodevelopmental disorders: current knowledge and saRNA future therapies. Roth C, Kilpinen H, Kurian MA, Barral S. Front Cell Dev Biol 11 1090046 (2023)
Articles citing this publication (45)
- Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. van Nuland R, Smits AH, Pallaki P, Jansen PW, Vermeulen M, Timmers HT. Mol Cell Biol 33 2067-2077 (2013)
- Structural analysis of the KANSL1/WDR5/KANSL2 complex reveals that WDR5 is required for efficient assembly and chromatin targeting of the NSL complex. Dias J, Van Nguyen N, Georgiev P, Gaub A, Brettschneider J, Cusack S, Kadlec J, Akhtar A. Genes Dev 28 929-942 (2014)
- Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation. Shinsky SA, Monteith KE, Viggiano S, Cosgrove MS. J Biol Chem 290 6361-6375 (2015)
- Crystal Structure of the COMPASS H3K4 Methyltransferase Catalytic Module. Hsu PL, Li H, Lau HT, Leonen C, Dhall A, Ong SE, Chatterjee C, Zheng N. Cell 174 1106-1116.e9 (2018)
- Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes. Alicea-Velázquez NL, Shinsky SA, Loh DM, Lee JH, Skalnik DG, Cosgrove MS. J Biol Chem 291 22357-22372 (2016)
- A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Yu X, Li D, Kottur J, Shen Y, Kim HS, Park KS, Tsai YH, Gong W, Wang J, Suzuki K, Parker J, Herring L, Kaniskan HÜ, Cai L, Jain R, Liu J, Aggarwal AK, Wang GG, Jin J. Sci Transl Med 13 eabj1578 (2021)
- WDR5 Stabilizes Actin Architecture to Promote Multiciliated Cell Formation. Kulkarni SS, Griffin JN, Date PP, Liem KF, Khokha MK. Dev Cell 46 595-610.e3 (2018)
- A phosphorylation switch on RbBP5 regulates histone H3 Lys4 methylation. Zhang P, Chaturvedi CP, Tremblay V, Cramet M, Brunzelle JS, Skiniotis G, Brand M, Shilatifard A, Couture JF. Genes Dev 29 123-128 (2015)
- A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes. Shinsky SA, Hu M, Vought VE, Ng SB, Bamshad MJ, Shendure J, Cosgrove MS. J Mol Biol 426 2283-2299 (2014)
- H3K4 Methyltransferase Set1a Is A Key Oct4 Coactivator Essential for Generation of Oct4 Positive Inner Cell Mass. Fang L, Zhang J, Zhang H, Yang X, Jin X, Zhang L, Skalnik DG, Jin Y, Zhang Y, Huang X, Li J, Wong J. Stem Cells 34 565-580 (2016)
- Landscape of the Plasmodium Interactome Reveals Both Conserved and Species-Specific Functionality. Hillier C, Pardo M, Yu L, Bushell E, Sanderson T, Metcalf T, Herd C, Anar B, Rayner JC, Billker O, Choudhary JS. Cell Rep 28 1635-1647.e5 (2019)
- Characterization of Two Distinct Nucleosome Remodeling and Deacetylase (NuRD) Complex Assemblies in Embryonic Stem Cells. Bode D, Yu L, Tate P, Pardo M, Choudhary J. Mol Cell Proteomics 15 878-891 (2016)
- Molecular basis for DPY-30 association to COMPASS-like and NURF complexes. Tremblay V, Zhang P, Chaturvedi CP, Thornton J, Brunzelle JS, Skiniotis G, Shilatifard A, Brand M, Couture JF. Structure 22 1821-1830 (2014)
- Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core. Tian J, Teuscher KB, Aho ER, Alvarado JR, Mills JJ, Meyers KM, Gogliotti RD, Han C, Macdonald JD, Sai J, Shaw JG, Sensintaffar JL, Zhao B, Rietz TA, Thomas LR, Payne WG, Moore WJ, Stott GM, Kondo J, Inoue M, Coffey RJ, Tansey WP, Stauffer SR, Lee T, Fesik SW. J Med Chem 63 656-675 (2020)
- Hat2p recognizes the histone H3 tail to specify the acetylation of the newly synthesized H3/H4 heterodimer by the Hat1p/Hat2p complex. Li Y, Zhang L, Liu T, Chai C, Fang Q, Wu H, Agudelo Garcia PA, Han Z, Zong S, Yu Y, Zhang X, Parthun MR, Chai J, Xu RM, Yang M. Genes Dev 28 1217-1227 (2014)
- The COMPASS-Like Complex Promotes Flowering and Panicle Branching in Rice. Jiang P, Wang S, Jiang H, Cheng B, Wu K, Ding Y. Plant Physiol 176 2761-2771 (2018)
- A SET-domain-independent role of WRAD complex in cell-cycle regulatory function of mixed lineage leukemia. Ali A, Veeranki SN, Tyagi S. Nucleic Acids Res 42 7611-7624 (2014)
- Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a "two-active site" model for multiple histone H3 lysine 4 methylation. Patel A, Vought VE, Swatkoski S, Viggiano S, Howard B, Dharmarajan V, Monteith KE, Kupakuwana G, Namitz KE, Shinsky SA, Cotter RJ, Cosgrove MS. J Biol Chem 289 868-884 (2014)
- WD repeat-containing protein 5 (WDR5) localizes to the midbody and regulates abscission. Bailey JK, Fields AT, Cheng K, Lee A, Wagenaar E, Lagrois R, Schmidt B, Xia B, Ma D. J Biol Chem 290 8987-9001 (2015)
- Facile target validation in an animal model with intracellularly expressed monobodies. Gupta A, Xu J, Lee S, Tsai ST, Zhou B, Kurosawa K, Werner MS, Koide A, Ruthenburg AJ, Dou Y, Koide S. Nat Chem Biol 14 895-900 (2018)
- Structural basis for histone mimicry and hijacking of host proteins by influenza virus protein NS1. Qin S, Liu Y, Tempel W, Eram MS, Bian C, Liu K, Senisterra G, Crombet L, Vedadi M, Min J. Nat Commun 5 3952 (2014)
- Structural basis of arginine asymmetrical dimethylation by PRMT6. Wu H, Zheng W, Eram MS, Vhuiyan M, Dong A, Zeng H, He H, Brown P, Frankel A, Vedadi M, Luo M, Min J. Biochem J 473 3049-3063 (2016)
- Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex. Shinsky SA, Cosgrove MS. J Biol Chem 290 25819-25833 (2015)
- WDR5 Facilitates Human Cytomegalovirus Replication by Promoting Capsid Nuclear Egress. Yang B, Liu XJ, Yao Y, Jiang X, Wang XZ, Yang H, Sun JY, Miao Y, Wang W, Huang ZL, Wang Y, Tang Q, Rayner S, Britt WJ, McVoy MA, Luo MH, Zhao F. J Virol 92 e00207-18 (2018)
- ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation. Gu Y, Chen Y, Wei L, Wu S, Shen K, Liu C, Dong Y, Zhao Y, Zhang Y, Zhang C, Zheng W, He J, Wang Y, Li Y, Zhao X, Wang H, Tan J, Wang L, Zhou Q, Xie G, Liang H, Ou J. Nat Commun 12 6711 (2021)
- Assembling a COMPASS. Couture JF, Skiniotis G. Epigenetics 8 349-354 (2013)
- Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia. Wingelhofer B, Somervaille TCP. Front Oncol 9 850 (2019)
- Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic. Li D, Yu X, Kottur J, Gong W, Zhang Z, Storey AJ, Tsai YH, Uryu H, Shen Y, Byrum SD, Edmondson RD, Mackintosh SG, Cai L, Liu Z, Aggarwal AK, Tackett AJ, Liu J, Jin J, Wang GG. Oncogene 41 3328-3340 (2022)
- Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization. Teuscher KB, Meyers KM, Wei Q, Mills JJ, Tian J, Alvarado J, Sai J, Van Meveren M, South TM, Rietz TA, Zhao B, Moore WJ, Stott GM, Tansey WP, Lee T, Fesik SW. J Med Chem 65 6287-6312 (2022)
- Targeting methyltransferase PRMT5 retards the carcinogenesis and metastasis of HNSCC via epigenetically inhibiting Twist1 transcription. Fan Z, He L, Li M, Cao R, Deng M, Ping F, Liang X, He Y, Wu T, Tao X, Xu J, Cheng B, Xia J. Neoplasia 22 617-629 (2020)
- The MLL1 trimeric catalytic complex is a dynamic conformational ensemble stabilized by multiple weak interactions. Kaustov L, Lemak A, Wu H, Faini M, Fan L, Fang X, Zeng H, Duan S, Allali-Hassani A, Li F, Wei Y, Vedadi M, Aebersold R, Wang Y, Houliston S, Arrowsmith CH. Nucleic Acids Res 47 9433-9447 (2019)
- Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions. Imran A, Moyer BS, Canning AJ, Kalina D, Duncan TM, Moody KJ, Wolfe AJ, Cosgrove MS, Movileanu L. Biochem J 478 2145-2161 (2021)
- Multistate structures of the MLL1-WRAD complex bound to H2B-ubiquitinated nucleosome. Rahman S, Hoffmann NA, Worden EJ, Smith ML, Namitz KEW, Knutson BA, Cosgrove MS, Wolberger C. Proc Natl Acad Sci U S A 119 e2205691119 (2022)
- Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models. Teuscher KB, Chowdhury S, Meyers KM, Tian J, Sai J, Van Meveren M, South TM, Sensintaffar JL, Rietz TA, Goswami S, Wang J, Grieb BC, Lorey SL, Howard GC, Liu Q, Moore WJ, Stott GM, Tansey WP, Lee T, Fesik SW. Proc Natl Acad Sci U S A 120 e2211297120 (2023)
- Interplay of Affinity and Surface Tethering in Protein Recognition. Imran A, Moyer BS, Wolfe AJ, Cosgrove MS, Makarov DE, Movileanu L. J Phys Chem Lett 13 4021-4028 (2022)
- Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling. Pardo M, Bode D, Yu L, Choudhary JS. J Vis Exp (2017)
- SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells. Jin ML, Yang L, Jeong KW. Theranostics 12 5761-5775 (2022)
- Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer. Yu X, Li D, Kottur J, Kim HS, Herring LE, Yu Y, Xie L, Hu X, Chen X, Cai L, Liu J, Aggarwal AK, Wang GG, Jin J. J Med Chem 66 16168-16186 (2023)
- Identification of putative SNPs in progressive retinal atrophy affected Canis lupus familiaris using exome sequencing. Reddy B, Kelawala DN, Shah T, Patel AB, Patil DB, Parikh PV, Patel N, Parmar N, Mohapatra AB, Singh KM, Menon R, Pandya D, Jakhesara SJ, Koringa PG, Rao MV, Joshi CG. Mamm Genome 26 638-649 (2015)
- Localization of the WD repeat-containing protein 5 to the Virion Assembly Compartment Facilitates Human Cytomegalovirus Assembly. Yang B, Yao Y, Wu H, Yang H, Ma XH, Li D, Wang XZ, Huang SN, Jiang X, Cheng S, Sun JY, Huang ZL, Zhao C, McVoy MA, Ahn JH, Zeng WB, Britt WJ, Gong S, Luo MH. J Virol 95 JVI.02101-20 (2021)
- Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site. Imran A, Moyer BS, Kalina D, Duncan TM, Moody KJ, Wolfe AJ, Cosgrove MS, Movileanu L. ACS Chem Biol 17 1586-1597 (2022)
- MLL1 is regulated by KSHV LANA and is important for virus latency. Tan M, Li S, Juillard F, Chitas R, Custódio TF, Xue H, Szymula A, Sun Q, Liu B, Álvarez ÁL, Chen S, Huang J, Simas JP, McVey CE, Kaye KM. Nucleic Acids Res 49 12895-12911 (2021)
- Congress Conference scene: 2nd cancer epigenetics conference. Smith CL. Epigenomics 5 123-130 (2013)
- Epigenetics: Disrupting histone lysine methylation. Trojer P. Nat Chem Biol 11 552-554 (2015)
- Wdr5-mediated H3K4me3 coordinately regulates cell differentiation, proliferation termination, and survival in digestive organogenesis. Zhang Z, Yang C, Wang Z, Guo L, Xu Y, Gao C, Sun Y, Zhang Z, Peng J, Hu M, Jan Lo L, Ma Z, Chen J. Cell Death Discov 9 227 (2023)